Pneuma Respiratory, a leader in inhaled respiratory therapeutics, today announced the results of a groundbreaking study examining the aerosol composit ...
Aerosol Delivery Devices Market Research Report In 2019, the aerosol delivery devices market is projected to reach $46.73 billion by 2027, ...
The "Nebulizer Patent Landscape Report" report has been added to ResearchAndMarkets.com's offering. A comprehensive analysis ...
Pneuma is accelerating its goal to improve respiratory health through the creation of strategic partnerships, aiming to rapidly deliver new solutions, at-scale, in the reduced-risk nicotine field. In ...
The Brighterside of News on MSN12d
Vaping may not lead to future cigarette smoking, study findsTobacco use remains one of the leading causes of preventable deaths worldwide, responsible for over 8 million deaths annually ...
Myrna B. Dolovich, PEng; Richard C. Ahrens, MD; Dean R. Hess, PhD, RRT, FCCP; Paula Anderson, MD, FCCP; Rajiv Dhand, MD, FCCP; Joseph L. Rau, PhD, RRT; Gerald C ...
Inhalation is a time-honored method of drug delivery, used primarily in the treatment of pulmonary disease. Aerosol medications have a number of advantages over oral administration, including the ...
Prices and availability are subject to change. It’s important to mention that nebulizers, which are devices that use compressed air to dilate airways and nebulizer medications, are not on their own a ...
2019; Yoon et al., 2017; Zhao et al., 2023). Over several decades, inhalation therapy, delivering high local therapeutic doses to the lungs, has emerged as a preferred treatment method for respiratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback